Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$21.60
-0.96%
Mkt Cap $1.58B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
Implied Upside
+71.3%
Consensus $37.00 vs current $21.60
NASDAQ·Healthcare·Biotechnology
$21.60
-0.96%
Mkt Cap $1.58B
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
+71.3%
Consensus $37.00 vs current $21.60